Meera Natarajan

Array ( [id] => 5887681 [patent_doc_number] => 20060275307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Antibodies to treat cancer' [patent_app_type] => utility [patent_app_number] => 11/497785 [patent_app_country] => US [patent_app_date] => 2006-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19960 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275307.pdf [firstpage_image] =>[orig_patent_app_number] => 11497785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5624869 [patent_doc_number] => 20060263374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Antibodies to treat cancer' [patent_app_type] => utility [patent_app_number] => 11/497642 [patent_app_country] => US [patent_app_date] => 2006-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19886 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20060263374.pdf [firstpage_image] =>[orig_patent_app_number] => 11497642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5148748 [patent_doc_number] => 20070048808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Hepatocellular carcinoma screening' [patent_app_type] => utility [patent_app_number] => 11/497155 [patent_app_country] => US [patent_app_date] => 2006-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7672 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20070048808.pdf [firstpage_image] =>[orig_patent_app_number] => 11497155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 256080 [patent_doc_number] => 07575748 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-08-18 [patent_title] => 'Methods of treatment using anti-ErbB antibody-maytansinoid conjugates' [patent_app_type] => utility [patent_app_number] => 11/488545 [patent_app_country] => US [patent_app_date] => 2006-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 47 [patent_no_of_words] => 28941 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/575/07575748.pdf [firstpage_image] =>[orig_patent_app_number] => 11488545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5135570 [patent_doc_number] => 20070077199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'Humanized collagen antibodies and related methods' [patent_app_type] => utility [patent_app_number] => 11/486894 [patent_app_country] => US [patent_app_date] => 2006-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 24861 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20070077199.pdf [firstpage_image] =>[orig_patent_app_number] => 11486894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7680713 [patent_doc_number] => 20100105873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'INTEGRATED APPROACH FOR GENERATING MULTIDOMAIN PROTEIN THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 11/993680 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 46636 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105873.pdf [firstpage_image] =>[orig_patent_app_number] => 11993680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5834684 [patent_doc_number] => 20060246515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'High throughput generation and affinity maturation of humanized antibody' [patent_app_type] => utility [patent_app_number] => 11/480037 [patent_app_country] => US [patent_app_date] => 2006-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 22078 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246515.pdf [firstpage_image] =>[orig_patent_app_number] => 11480037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6576723 [patent_doc_number] => 20100047245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'IL-12/P40 BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 11/478096 [patent_app_country] => US [patent_app_date] => 2006-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50632 [patent_no_of_claims] => 135 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047245.pdf [firstpage_image] =>[orig_patent_app_number] => 11478096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 602595 [patent_doc_number] => 07432358 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-07 [patent_title] => 'Oncogene, recombinant protein derived therefrom, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/449671 [patent_app_country] => US [patent_app_date] => 2006-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 22578 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/432/07432358.pdf [firstpage_image] =>[orig_patent_app_number] => 11449671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13168 [patent_doc_number] => 07807379 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker' [patent_app_type] => utility [patent_app_number] => 11/449869 [patent_app_country] => US [patent_app_date] => 2006-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 21 [patent_no_of_words] => 14521 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807379.pdf [firstpage_image] =>[orig_patent_app_number] => 11449869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6581204 [patent_doc_number] => 20100291083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Novel Analgesic Treatment with Prolonged Effect' [patent_app_type] => utility [patent_app_number] => 11/921398 [patent_app_country] => US [patent_app_date] => 2006-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6014 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291083.pdf [firstpage_image] =>[orig_patent_app_number] => 11921398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4971267 [patent_doc_number] => 20070111269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'METHOD TO PREDICT POSITIVE REPEAT PROSTATE BIOPSY' [patent_app_type] => utility [patent_app_number] => 11/420113 [patent_app_country] => US [patent_app_date] => 2006-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12987 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20070111269.pdf [firstpage_image] =>[orig_patent_app_number] => 11420113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5619395 [patent_doc_number] => 20060188928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Gene causative of Rothmund-Thomson syndrome and gene product' [patent_app_type] => utility [patent_app_number] => 11/415100 [patent_app_country] => US [patent_app_date] => 2006-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15243 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20060188928.pdf [firstpage_image] =>[orig_patent_app_number] => 11415100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5050878 [patent_doc_number] => 20070031423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Antibodies to treat cancer' [patent_app_type] => utility [patent_app_number] => 11/414532 [patent_app_country] => US [patent_app_date] => 2006-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19921 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20070031423.pdf [firstpage_image] =>[orig_patent_app_number] => 11414532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851080 [patent_doc_number] => 20060234271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'METHODS FOR THE DIAGNOSIS AND TREATMENT OF METASTATIC PROSTATE TUMORS' [patent_app_type] => utility [patent_app_number] => 11/380592 [patent_app_country] => US [patent_app_date] => 2006-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 23837 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234271.pdf [firstpage_image] =>[orig_patent_app_number] => 11380592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539989 [patent_doc_number] => 20090221794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Human Protooncogene and Protein Encoded By Same' [patent_app_type] => utility [patent_app_number] => 11/910010 [patent_app_country] => US [patent_app_date] => 2006-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 77 [patent_figures_cnt] => 77 [patent_no_of_words] => 32159 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221794.pdf [firstpage_image] =>[orig_patent_app_number] => 11910010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4812824 [patent_doc_number] => 20080193455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Novel Anti-Plgf A Antibody' [patent_app_type] => utility [patent_app_number] => 11/909604 [patent_app_country] => US [patent_app_date] => 2006-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14686 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20080193455.pdf [firstpage_image] =>[orig_patent_app_number] => 11909604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 151091 [patent_doc_number] => 07678371 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-16 [patent_title] => 'Methods of humanizing immunoglobulin variable regions through rational modification of complementarity determining residues' [patent_app_type] => utility [patent_app_number] => 11/369641 [patent_app_country] => US [patent_app_date] => 2006-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 28678 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/678/07678371.pdf [firstpage_image] =>[orig_patent_app_number] => 11369641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5085370 [patent_doc_number] => 20070275421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Detection of dysplastic or neoplastic cells using anti-MCM2 antibodies' [patent_app_type] => utility [patent_app_number] => 11/365659 [patent_app_country] => US [patent_app_date] => 2006-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15852 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275421.pdf [firstpage_image] =>[orig_patent_app_number] => 11365659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 299695 [patent_doc_number] => 07537894 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-26 [patent_title] => 'Methods and kits for monitoring Barrett\'s metaplasia' [patent_app_type] => utility [patent_app_number] => 11/367602 [patent_app_country] => US [patent_app_date] => 2006-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 8239 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/537/07537894.pdf [firstpage_image] =>[orig_patent_app_number] => 11367602 [rel_patent_id] =>[rel_patent_doc_number] =>)